1-24063151-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000374434.4(MYOM3):āc.3745T>Cā(p.Tyr1249His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,611,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000040 ( 0 hom., cov: 32)
Exomes š: 0.000015 ( 0 hom. )
Consequence
MYOM3
ENST00000374434.4 missense
ENST00000374434.4 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 1.96
Genes affected
MYOM3 (HGNC:26679): (myomesin 3) Predicted to enable actin filament binding activity and protein homodimerization activity. Predicted to be involved in muscle contraction. Predicted to be active in M band. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06107065).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOM3 | NM_152372.4 | c.3745T>C | p.Tyr1249His | missense_variant | 32/37 | ENST00000374434.4 | NP_689585.3 | |
LOC107984931 | XR_001737929.1 | n.276-896A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM3 | ENST00000374434.4 | c.3745T>C | p.Tyr1249His | missense_variant | 32/37 | 1 | NM_152372.4 | ENSP00000363557 | P1 | |
ENST00000439239.2 | n.178-896A>G | intron_variant, non_coding_transcript_variant | 5 | |||||||
MYOM3 | ENST00000338909.9 | c.424T>C | p.Tyr142His | missense_variant | 5/10 | 2 | ENSP00000342689 | |||
MYOM3 | ENST00000448831.1 | n.188-6825T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151550Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151550
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000641 AC: 16AN: 249552Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135394
GnomAD3 exomes
AF:
AC:
16
AN:
249552
Hom.:
AF XY:
AC XY:
10
AN XY:
135394
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460270Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726182
GnomAD4 exome
AF:
AC:
22
AN:
1460270
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
726182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151550Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 73984
GnomAD4 genome
AF:
AC:
6
AN:
151550
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
73984
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.3745T>C (p.Y1249H) alteration is located in exon 32 (coding exon 31) of the MYOM3 gene. This alteration results from a T to C substitution at nucleotide position 3745, causing the tyrosine (Y) at amino acid position 1249 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;P
Vest4
MutPred
0.41
.;Loss of phosphorylation at Y1249 (P = 0.0497);
MVP
MPC
0.12
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at